Vector-driven hyperexpression of a triad of costimulatory molecules confers enhanced T-cell stimulatory capacity to DC precursors

Ariel N. Rad, Jeffrey Schlom, James W. Hodge

Research output: Contribution to journalArticle

Abstract

Activation of T cells requires at least two signals: signal 1, via the T-cell receptor, and signal 2, in which a costimulatory molecule on the antigen presenting cell (APC) interacts with a ligand on the T cell. Dendritic cells (DCs) are the most potent APCs in part due to their expression of costimulatory molecules. DCs, however, constitute only a minor percentage of APCs in the body, and the in vitro preparation of DCs is both costly and time consuming. The studies reported here demonstrate that one can utilize other APCs, such as bone marrow progenitor cells (BMPCs) and make them markedly more effective as APCs; this was accomplished by their infection with recombinant poxviruses (either the replication-defective avipox or vaccinia), which contain transgenes for a triad of costimulatory molecules (B7-1, ICAM-1 and LFA-3, designated TRICOM). APCs infected with TRICOM vectors are shown to significantly enhance the activation of both naive and effector CD4+ and CD8+ T-cell populations. The use of TRICOM vectors in vaccine strategies is discussed.

Original languageEnglish (US)
Pages (from-to)43-57
Number of pages15
JournalCritical Reviews in Oncology/Hematology
Volume39
Issue number1-2
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Dendritic Cells
T-Lymphocytes
CD80 Antigens
CD58 Antigens
Poxviridae
Vaccinia
Antigen-Presenting Cells
Intercellular Adhesion Molecule-1
T-Cell Antigen Receptor
Transgenes
Bone Marrow Cells
Stem Cells
Vaccines
Ligands
Infection
Population
In Vitro Techniques

Keywords

  • Bone marrow
  • Costimulation
  • Fowlpox
  • T cells
  • Vaccine
  • Vaccinia

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Vector-driven hyperexpression of a triad of costimulatory molecules confers enhanced T-cell stimulatory capacity to DC precursors. / Rad, Ariel N.; Schlom, Jeffrey; Hodge, James W.

In: Critical Reviews in Oncology/Hematology, Vol. 39, No. 1-2, 2001, p. 43-57.

Research output: Contribution to journalArticle

@article{2a6e05b9389d46aaabb58d299d9ca328,
title = "Vector-driven hyperexpression of a triad of costimulatory molecules confers enhanced T-cell stimulatory capacity to DC precursors",
abstract = "Activation of T cells requires at least two signals: signal 1, via the T-cell receptor, and signal 2, in which a costimulatory molecule on the antigen presenting cell (APC) interacts with a ligand on the T cell. Dendritic cells (DCs) are the most potent APCs in part due to their expression of costimulatory molecules. DCs, however, constitute only a minor percentage of APCs in the body, and the in vitro preparation of DCs is both costly and time consuming. The studies reported here demonstrate that one can utilize other APCs, such as bone marrow progenitor cells (BMPCs) and make them markedly more effective as APCs; this was accomplished by their infection with recombinant poxviruses (either the replication-defective avipox or vaccinia), which contain transgenes for a triad of costimulatory molecules (B7-1, ICAM-1 and LFA-3, designated TRICOM). APCs infected with TRICOM vectors are shown to significantly enhance the activation of both naive and effector CD4+ and CD8+ T-cell populations. The use of TRICOM vectors in vaccine strategies is discussed.",
keywords = "Bone marrow, Costimulation, Fowlpox, T cells, Vaccine, Vaccinia",
author = "Rad, {Ariel N.} and Jeffrey Schlom and Hodge, {James W.}",
year = "2001",
doi = "10.1016/S1040-8428(01)00123-8",
language = "English (US)",
volume = "39",
pages = "43--57",
journal = "Critical Reviews in Oncology/Hematology",
issn = "1040-8428",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

TY - JOUR

T1 - Vector-driven hyperexpression of a triad of costimulatory molecules confers enhanced T-cell stimulatory capacity to DC precursors

AU - Rad, Ariel N.

AU - Schlom, Jeffrey

AU - Hodge, James W.

PY - 2001

Y1 - 2001

N2 - Activation of T cells requires at least two signals: signal 1, via the T-cell receptor, and signal 2, in which a costimulatory molecule on the antigen presenting cell (APC) interacts with a ligand on the T cell. Dendritic cells (DCs) are the most potent APCs in part due to their expression of costimulatory molecules. DCs, however, constitute only a minor percentage of APCs in the body, and the in vitro preparation of DCs is both costly and time consuming. The studies reported here demonstrate that one can utilize other APCs, such as bone marrow progenitor cells (BMPCs) and make them markedly more effective as APCs; this was accomplished by their infection with recombinant poxviruses (either the replication-defective avipox or vaccinia), which contain transgenes for a triad of costimulatory molecules (B7-1, ICAM-1 and LFA-3, designated TRICOM). APCs infected with TRICOM vectors are shown to significantly enhance the activation of both naive and effector CD4+ and CD8+ T-cell populations. The use of TRICOM vectors in vaccine strategies is discussed.

AB - Activation of T cells requires at least two signals: signal 1, via the T-cell receptor, and signal 2, in which a costimulatory molecule on the antigen presenting cell (APC) interacts with a ligand on the T cell. Dendritic cells (DCs) are the most potent APCs in part due to their expression of costimulatory molecules. DCs, however, constitute only a minor percentage of APCs in the body, and the in vitro preparation of DCs is both costly and time consuming. The studies reported here demonstrate that one can utilize other APCs, such as bone marrow progenitor cells (BMPCs) and make them markedly more effective as APCs; this was accomplished by their infection with recombinant poxviruses (either the replication-defective avipox or vaccinia), which contain transgenes for a triad of costimulatory molecules (B7-1, ICAM-1 and LFA-3, designated TRICOM). APCs infected with TRICOM vectors are shown to significantly enhance the activation of both naive and effector CD4+ and CD8+ T-cell populations. The use of TRICOM vectors in vaccine strategies is discussed.

KW - Bone marrow

KW - Costimulation

KW - Fowlpox

KW - T cells

KW - Vaccine

KW - Vaccinia

UR - http://www.scopus.com/inward/record.url?scp=0034966940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034966940&partnerID=8YFLogxK

U2 - 10.1016/S1040-8428(01)00123-8

DO - 10.1016/S1040-8428(01)00123-8

M3 - Article

C2 - 11418301

AN - SCOPUS:0034966940

VL - 39

SP - 43

EP - 57

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

IS - 1-2

ER -